Showing results (1-10 of 125) with videos related to
Sort By:
Pageof 13
European Journal of Neurology|February 21, 2023
Long COVID: Does SARS-CoV-2 induce lingering brain lesions?Jacques HugonMorphologie : Bulletin De L'Association Des Anatomistes|December 7, 2007
[Molecular and therapeutic approaches of the Alzheimer's disease]Jacques Hugon, Claire PaquetInternational Journal of Molecular Sciences|April 3, 2021
The PKR/P38/RIPK1 Signaling Pathway as a Therapeutic Target in Alzheimer's DiseaseJacques Hugon, Claire PaquetJournal of Cellular and Molecular Medicine|February 13, 2009
mTOR-dependent signalling in Alzheimer's diseaseJin-Jing Pei, Jacques HugonJournal of Neurochemistry|June 18, 2002
Involvement of glycogen synthase kinase-3beta and tau phosphorylation in neuronal Golgi disassemblyWassim Elyaman, Catherine Yardin, Jacques HugonFrontiers in Neurology|August 25, 2015
Pro-Apoptotic Kinase Levels in Cerebrospinal Fluid as Potential Future Biomarkers in Alzheimer's DiseaseClaire Paquet, Julien Dumurgier, Jacques HugonAlzheimer'S Research & Therapy|October 7, 2017
PKR involvement in Alzheimer's diseaseJacques Hugon, François Mouton-Liger, Julien Dumurgier, et al.FEBS Letters|April 23, 2011
Modulation of oxidative stress and tau phosphorylation by the mTOR activator phosphatidic acid in SH-SY5Y cellsMariko Taga, François Mouton-Liger, Claire Paquet, et al.Brain Research|December 8, 2019
Dose-dependent neuroprotective effect of the JNK inhibitor Brimapitide in 5xFAD transgenic miceBaptiste Porte, Gwendolyn Marguerit, Sylvie Thomasseau, et al.Pageof 13